439 related articles for article (PubMed ID: 31131616)
41. Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson's disease: A randomised controlled trial.
Ibrahim A; Ali RAR; Manaf MRA; Ahmad N; Tajurruddin FW; Qin WZ; Desa SHM; Ibrahim NM
PLoS One; 2020; 15(12):e0244680. PubMed ID: 33382780
[TBL] [Abstract][Full Text] [Related]
42. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial.
Søndergaard B; Olsson J; Ohlson K; Svensson U; Bytzer P; Ekesbo R
Scand J Gastroenterol; 2011 Jun; 46(6):663-72. PubMed ID: 21443416
[TBL] [Abstract][Full Text] [Related]
43. A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms.
Kalman DS; Schwartz HI; Alvarez P; Feldman S; Pezzullo JC; Krieger DR
BMC Gastroenterol; 2009 Nov; 9():85. PubMed ID: 19922649
[TBL] [Abstract][Full Text] [Related]
44. Bacillus coagulans Unique IS2 in Constipation: A Double-Blind, Placebo-Controlled Study.
Madempudi RS; Neelamraju J; Ahire JJ; Gupta SK; Shukla VK
Probiotics Antimicrob Proteins; 2020 Jun; 12(2):335-342. PubMed ID: 30911991
[TBL] [Abstract][Full Text] [Related]
45. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial.
Begtrup LM; de Muckadell OB; Kjeldsen J; Christensen RD; Jarbøl DE
Scand J Gastroenterol; 2013 Oct; 48(10):1127-35. PubMed ID: 23957590
[TBL] [Abstract][Full Text] [Related]
46. The effect of probiotics on faecal microbiota and genotoxic activity of faecal water in patients with atopic dermatitis: a randomized, placebo-controlled study.
Roessler A; Forssten SD; Glei M; Ouwehand AC; Jahreis G
Clin Nutr; 2012 Feb; 31(1):22-9. PubMed ID: 21963389
[TBL] [Abstract][Full Text] [Related]
47. A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome.
Roberts LM; McCahon D; Holder R; Wilson S; Hobbs FD
BMC Gastroenterol; 2013 Mar; 13():45. PubMed ID: 23496803
[TBL] [Abstract][Full Text] [Related]
48. Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study.
Childs CE; Röytiö H; Alhoniemi E; Fekete AA; Forssten SD; Hudjec N; Lim YN; Steger CJ; Yaqoob P; Tuohy KM; Rastall RA; Ouwehand AC; Gibson GR
Br J Nutr; 2014 Jun; 111(11):1945-56. PubMed ID: 24661576
[TBL] [Abstract][Full Text] [Related]
49. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults.
Klein A; Friedrich U; Vogelsang H; Jahreis G
Eur J Clin Nutr; 2008 May; 62(5):584-93. PubMed ID: 17440520
[TBL] [Abstract][Full Text] [Related]
50. Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: a randomized, double-blind, controlled study in chronic constipation.
Magro DO; de Oliveira LM; Bernasconi I; Ruela Mde S; Credidio L; Barcelos IK; Leal RF; Ayrizono Mde L; Fagundes JJ; Teixeira Lde B; Ouwehand AC; Coy CS
Nutr J; 2014 Jul; 13():75. PubMed ID: 25056655
[TBL] [Abstract][Full Text] [Related]
51. Three probiotic strains exert different effects on plasma bile acid profiles in healthy obese adults: randomised, double-blind placebo-controlled crossover study.
Culpepper T; Rowe CC; Rusch CT; Burns AM; Federico AP; Girard SA; Tompkins TA; Nieves C; Dennis-Wall JC; Christman MC; Langkamp-Henken B
Benef Microbes; 2019 May; 10(5):497-509. PubMed ID: 31090458
[TBL] [Abstract][Full Text] [Related]
52. The probiotic
Garvey SM; Mah E; Blonquist TM; Kaden VN; Spears JL
Gut Microbes; 2022; 14(1):2122668. PubMed ID: 36269141
[TBL] [Abstract][Full Text] [Related]
53. Effectiveness and Safety of Probiotics for Patients with Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials.
Shang X; E FF; Guo KL; Li YF; Zhao HL; Wang Y; Chen N; Nian T; Yang CQ; Yang KH; Li XX
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745212
[TBL] [Abstract][Full Text] [Related]
54. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.
Guyonnet D; Chassany O; Ducrotte P; Picard C; Mouret M; Mercier CH; Matuchansky C
Aliment Pharmacol Ther; 2007 Aug; 26(3):475-86. PubMed ID: 17635382
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of Polydextrose Supplementation on Colonic Transit Time, Bowel Movements, and Gastrointestinal Symptoms in Adults: A Double-Blind, Randomized, Placebo-Controlled Trial.
Ibarra A; Pelipyagina T; Rueffer M; Evans M; Ouwehand AC
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30791557
[TBL] [Abstract][Full Text] [Related]
56. A probiotic amylase blend reduces gastrointestinal symptoms in a randomised clinical study.
La Monica MB; Raub B; Lopez HL; Ziegenfuss TN
Benef Microbes; 2023 Oct; 14(5):459-476. PubMed ID: 38350481
[TBL] [Abstract][Full Text] [Related]
57. A prospective, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of SNZ TriBac, a three-strain Bacillus probiotic blend for undiagnosed gastrointestinal discomfort.
Soman RJ; Swamy MV
Int J Colorectal Dis; 2019 Nov; 34(11):1971-1978. PubMed ID: 31686199
[TBL] [Abstract][Full Text] [Related]
58. Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: a randomized clinical trial.
Compare D; Rocco A; Sgamato C; Coccoli P; Campo SM; Nazionale I; Larussa T; Luzza F; Chiodini P; Nardone G
Dig Liver Dis; 2015 Apr; 47(4):273-9. PubMed ID: 25660822
[TBL] [Abstract][Full Text] [Related]
59. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Yoon JS; Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Chung WS; Seo JG
J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of synbiotic, probiotic, and prebiotic treatments for irritable bowel syndrome in children: A randomized controlled trial.
Baştürk A; Artan R; Yılmaz A
Turk J Gastroenterol; 2016 Sep; 27(5):439-443. PubMed ID: 27782892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
